Agree Goldman. Shareprice performance has been abysmal despite albeit slow progress on getting to Phase 3 status this year.
Talk of big pharma deal does not seem credible. I f big pharma were that excited by PAR why not just do a complete takeover on PAR given its micro capitalisation?
Something needs to give- either do a deal or be taken over. I do think the longer time goes on without a deal, the higher the risk becomes, not the other way around.
PAR Investor Meeting - Questions from HC, page-39
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.5¢ | $86.19K | 286.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 70151 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18600 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |